Skip to content

Simply CMT

Accelerating Research. Empowering Patients. Making It Make Sense.

Featured News


All News

Search Simply CMT by Category

Search Simply CMT by Category
  • CMTA Announces Its First Center of Excellence in Scotland
    New CMTA Center of Excellence in Glasgow

    The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research, is…

  • CMTA-STAR Advisory Board Member Dr. D’Antonio Publishes in Brain, Identifies Potential Therapeutic Target for CMT1B
    CMTA-STAR Advisor Publishes in Brain, Identifies CMT Treatment Target

    CMTA is proud to share that research led by CMTA Strategy to Accelerate Research (CMTA-STAR)…

  • Accelerating Genetic Therapy for CMT4B1: A CMTA Research Update
    CMTA Advances Genetic Therapy Research for CMT4B1 with $380K Investment

    With CMTA’s support, researchers at San Raffaele Scientific Institute in Milan, Italy, led by Alessandra…

  • CMTA’s $300K Investment in CRISPR for CMT2A
    CMTA Invests $300K in CRISPR Gene Editing Research for CMT2A

    The Charcot-Marie-Tooth Association (CMTA) is investing $300,000 in a groundbreaking gene editing research project at…

  • What’s New in CMT Research and Care? A 2025 Update Published by CMTA-STAR Advisory Board Member Davide Pareyson, MD
    What’s New in CMT: Update from CMTA-STAR’s Davide Pareyson, MD

    CMTA Strategy To Accelerate Research (CMTA-STAR) Advisory Board member and clinic director of the CMTA…

  • CMTA Announces New Center of Excellence at UPMC in Pittsburgh, Pennsylvania
    CMTA Announces New Center of Excellence at UPMC in Pittsburgh, PA

    The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research, is…

  • CMTA Fuels Breakthrough Imaging Research to Address CMT2A’s Cellular Weakness
    CMTA Funds AI-Driven Imaging Research for CMT2A Treatment

    The Charcot-Marie-Tooth Association (CMTA) announces a $90,860 investment in a new imaging research project at…

  • Episode 3 of the Simply CMT Podcast with Dr. Katherine Forsey
    Episode 3 of the Simply CMT Podcast with Dr. Katherine Forsey

    Join us as we talk with Dr. Katherine Forsey, CMTA’s Chief Research Officer. Dr. Forsey…

  • Actio Biosciences Doses First Participant in Phase I Clinical Trial | Future Phase Ib Clinical Trial to Focus on CMT2C
    Actio Biosciences Doses First Participant in Phase I Trial

    CMTA-STAR Alliance Partner Actio Biosciences has announced that the first participant has been dosed in its Phase…

  • CMTA Films Presents Jonah Berger
    CMTA Films Presents Jonah Berger

    CMTA Films presents Jonah Berger, CMTA’s National Youth Programs Manager, as he shares his journey…

  • CMTA Partners with BILLY Footwear
    CMTA Partners with BILLY Footwear

    The Charcot-Marie-Tooth Association (CMTA) is excited to announce a new partnership with BILLY Footwear. When…

  • Statement from CMTA’s Chief Executive Officer, Sue Bruhn, PhD
    Statement from CMTA’s Chief Executive Officer, Sue Bruhn, PhD

    Dear Members of the CMT Community, The Charcot-Marie-Tooth Association (CMTA) continues to prioritize the well-being…